Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLCYongyuan Chen, Pin Wu, Zhixing Hao et al.|Journal for ImmunoTherapy of Cancer|2024Cited by 15